Free radicals: Their history and current status in aging and disease

Annals of Clinical and Laboratory Science

Volumn 28, Issue 6, 1998, Pages 331-346

  Knight, Joseph A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIOXIDANT; BETA CAROTENE; CAROTENOID; CATALASE; CERULOPLASMIN; FERRITIN; FLAVONOID; FREE RADICAL; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEMOGLOBIN; LYCOPENE; METALLOTHIONEIN; OXYGEN; PHENOTHIAZINE; PHOTOSENSITIZING AGENT; SCAVENGER; SUPEROXIDE DISMUTASE; TETRACYCLINE; TRANSFERRIN;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CANCER; CARCINOGENESIS; CATARACT; DEGENERATIVE DISEASE; DIABETES MELLITUS; HUMAN; NEUROLOGIC DISEASE; NONHUMAN; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REPERFUSION INJURY; RETINA MACULA DEGENERATION;

AGING; ANTIOXIDANTS; DISEASE; FREE RADICALS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; OXIDATIVE STRESS;

EID: 0031741551     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (132)

1. Fenton HJH. Oxidation of tartaric acid in presence of iron. J Chem Soc 1894;65:899-910.
2. Gomberg M. An instance of trivalent carbon: triphenylmethyl. J Am Chem Soc 1900;22:757-71.
3. Binger CAL, Faulkner JM, Moore RL. Oxygen poisoning in mammals. J Exp Med 1927;45:849-64.
4. Smith JL. Pathological effects due to increase of oxygen tension in air breathed. J Physiol 1899;24:19-35.
5. Harvey AM, McKusick VA, eds. Osler's Textbook Revisited. New York: Appleton-Century-Crofts, 1967:103.
6. Comroe JH Jr, Dripps RD, Dumke PR, Deming M. Oxygen Toxicity. J Am Med Assoc 1945;128:710-7.
7. Southern PA, Powis G. Free radicals in medicine. II. Involvement in human disease. Mayo Clin Proc 1988;63:390-408.
8. Nash G, Blennerhassett JB, Pontoppidan H. Pulmonary lesions associated with oxygen therapy and artificial ventilation. N Engl J Med 1967;276:368-74.
9. Soloway HB, Castillo Y, Martin AM Jr. Adult hyaline membrane disease: relationship to oxygen therapy. Ann Surg 1968;168:937-45.
10. Gerschman R, Gilbert DL, Nye SW, Dwyer P, Fenn WO. Oxygen poisoning and X-irradiation: A mechanism in common. Science 1954;119:623-6.
11. Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984;219:1-14.
12. McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244:6049-55.
13. Ames BN, Shigenago MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915-22.
14. Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956;11:298-300.
15. Pacifici RE, Davies KJA. Protein, lipid and DNA repair systems in oxidative stress: The free-radical theory of agng revisited. Gerontol 1990;37:166-80.
16. Sohal RS, Allen RG. Oxidative stress as a causal factor in differentiation and aging: A unifying hypothesis. Exper Gerontol 1990;25:499-522.
17. Rusting RL. Why do we age? Sci Amer 1992;267: 130-44.
18. Pearl R. The Rate of Living. New York: Knopf, 1928.
19. Smith DWE. Human Longevity. New York: Oxford University Press, 1993:9.
20. McCay CM, Crowell MF, Maynard LA. The effect of retarded growth upon the length of life span and upon the ultimate body size. J Nutr 1935;10:63-79.
21. Yu BP, Masoro EJ, McMahan CA. Nutritional influences on aging of Fischer 344 rats: I. Physical, metabolic, and longevity characteristics. J Gerontol 1985; 40:657-70.
22. Koizumi A, Weindruck R, Walford RL. Influence of dietary restriction and aging on liver enzyme activities and lipid peroxidation in mice. J Nutr 1987;117: 361-7.
23. Chung MH, Kasai H, Nishimura S, et al. Protection of DNA damage by dietary restriction. Free Rad Biol Med 1992;12:523-5.
24. Lane MA, Baer DJ, Rumpler WV, et al. Calorie restriction lowers body temperature in rhesus monkeys, consistent with a postulated anti-aging mechanism in rodents. Proc Natl Acad Sci USA 1996;93: 4159-64.
25. Weed JL, Lane MA, Roth GS, Speer DL, Ingram DK. Activity measure in rhesus monkeys on long-term calorie restriction. Physiol Behav 1997;62:97-103.
26. Lane MA, Ingram DK, Ball SS, Roth GS. Dehydroepiandrosterone sulfate: A biomarker of primate aging slowed by calorie restriction. J Clin Endocrinol Metab 1997;82:2093-6.
27. Orr WC, Sohal RS. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 1994;263:1128-30.
28. Paolisso G, Tagliamonte MR, Rizzo MP, et al. Oxidative stress and advancing age: Results in healthy centenarians. J Am Geriatr Soc 1998;46:833-8.
29. Glavind J, Hartman S, Clemmensen J, et al. Studies on the role of lipoperoxides in human pathology: The presence of peroxidized lipids in atherosclerotic aorta. Acta Pathol Microbiol Scand 1952;30:1-6.
30. Parthasarathy S, Fong LC, Steinberg D. Oxidative modification of low density lipoprotein and atherosclerosis: concepts and consequences. In: Sevanian A, ed. Lipid Peroxidation in Biological Systems. Champaign, IL: Am Oil Chem Soc, 1987:225-35.
31. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
32. Quinn MT, Parthasarathy S, Fong LC, Steinberg D. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocytes/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987;84:2995-8.
33. Steinberg D. Antioxidants and atherosclerosis: A current assessment. Circulation 1991;84:1420-5.
34. Steinberg D. Modified forms of low-density lipoproteins and atherosclerosis. J Intern Med 1993;233: 227-32.
35. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low-density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest 1987;74:1890-4.
36. Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984;4:356-64.
37. Steinbrecher UP, Parthasarathy L, Leake DS, et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984;83:3883-7.
38. Palinski W, Rosenfeld ME, Yla-Herttuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989;86: 1372-6.
39. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-7.
40. Maggi E, Chiesa R, Melissano G, et al. LDL oxidation in patients with severe carotid atherosclerosis: a study of in vitro and in vivo oxidation markers. Arterioscler Thromb 1994;14:1892-9.
41. Yla-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-95.
42. Yla-Herttuala S, Rosenfeld ME, Parthasarathy S, et al. Gene expression in macrophage-rich human atherosclerotic lesions: 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 1991;87:1146-52.
43. Heinecke JW, Baker H, Rosen H, Chait A. Superoxide mediated modification of low density lipoprotein by human arterial smooth muscle cells. J Clin Invest 1986;77:757-62.
44. Van der Vliet A, Smith D, O'Neil CA, et al. Interactions of peroxynitrite with human plasma and its constituents: Oxidative damage and antioxidant depletion. Biochem J 1994;303:295-301.
45. Moore KP, Darley-Usmar V, Morrow J, Roberts LJ. Formation of F2-isoprostanes during oxidation of human low density lipoprotein and plasma by peroxynitrite. Circ Res 1995;77:335-41.
46. Parthasarathy S, Young SG, Wiztum JL, Pitman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986; 77:641-4.
47. Frei B. Ascorbic acid protects lipids in human plasma and low density lipoprotein against oxidative damage. Am J Clin Nutr 1991;54:1113S-8S.
48. Jialal I, Grundy SM. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest 1991;87:597-601.
49. Wojcicki J, Rozewicka B, Barcew-Wiszniewska B, et al. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 1991;87:9-16.
50. Verlangier AJ, Bush MJ. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 1992;11:131-8.
51. Prasad K, Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J 1993;125:958-73.
52. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53:326S-34S.
53. Stampfer MJ, Hennekins CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9.
54. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
55. Khalil A, Wagner JR, Lacombe G, et al. Increased susceptibility of low-density lipoprotein (LDL) to oxidation by gamma-radiolysis with age. FEBS Lett 1996;392:45-8.
56. Gerster H. Review: Antioxidant protection of the ageing macula. Age Ageing 1991;20:60-9.
57. Young RW. Solar radiation and age-related macular degeneration. Surv Ophthalmol 1988;32:252-69.
58. Katz ML, Robinson WG, Dratz EA. Potential role of autoxidation in age changes in the retina and retinal pigment epithelium of the eye. In: Armstrong D, Sohal RS, Cutler RG, Slater TF, eds. Free Radicals in Molecular Biology, Aging and Disease. New York: Raven Press, 1984:163-80.
59. Seddon JM, Christen WC, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Pub Health 1994; 84:788-92.
60. Jaques PF, Chylack LT Jr. Epidemiologic evidence for a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 1991; 53:352S-5S.
61. Garland DL. Ascorbic acid and the eye. Am J Clin Nutr 1991;54:1198S-202S.
62. Knight JA. Reactive oxygen species and the neurodegenerative disorders. Ann Clin Lab Sci 1997;27: 11-25.
63. Ravindranath V, Shivakumar BR, Anandatheerthavarada HK. Low glutathione levels in brain regions of aged rats. Neurosci Lett 1989;101:187-90.
64. Cohen G. Oxygen radicals in Parkinson's disease. In: Halliwell B, ed. Oxygen Radicals and Tissue Injury. FASEB 1988:130-5.
65. Stocks J, Gutteridge JMC, Sharp RJ, Dormandy TL. The inhibition of lipid peroxidation by human serum and its relationship to serum proteins and alpha-tocopherol. Clin Sci 1974;47:223-33.
66. Poulin JE, Cover C, Gustafson MR, Kay MMB. Vitamin E prevents oxidative modification of brain and lymphocyte band 3 proteins during aging. Proc Natl Acad Sci USA 1996;93:5600-3.
67. Halliwell B. Oxidants and the central nervous system: some fundamental questions. Acta Neurol Scand 1989;126:23-33.
68. Evans PH. Free radicals in brain metabolism and pathology. Br Med Bull 1993;49:577-87.
69. Jenner P. Oxidative damage in neurodegenerative disease. Lancet 1994;344:796-8.
70. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
71. Deng H-X, Hentati A, Trainer JA, et al. Amyotrophic lateral sclerosis and structured defects in Cu,Zn superoxide dismutase. Science 1993;261:1047-51.
72. 10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA 1998;95:8892-7.
73. Rosen DR, Bowling AC, Patterson D, et al. A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Hum Mol Genet 1994;3: 981-7.
74. Gurney ME, Pu H, Chin AY, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994;264: 1772-5.
75. Brown RH. Clinical implications of basic research: A transgenic-mouse model of amyotrophic lateral sclerosis. N Engl J Med 1994;331:1091-2.
76. Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and peroxynitrite. Nature 1993;364:584.
77. Borek C. Antioxidants and cancer. Sci Med 1997; Nov/Dec:52-61.
78. Floyd RA, Watson JJ, Harris J, et al. Formation of 8-hydroxy deoxyguanosine, hydroxyl free radical adduct of DNA in granulocytes exposed to tumor promotor, tetradecanoyl phorbolacetate. Biochem Biophys Res Commun 1986;137:841-6.
79. Kaneko M, Leadon SA. Production of thymine glycols in DNA by N-hydroxy-2-naphthylamine as detected by a monoclonal antibody. Cancer Res 1986;46:71-5.
80. Kasai H, Nishimura S, Kurokawa Y, Hayashi Y. Oral administration of the renal carcinogen potassium bromate, specifically promotes 8-hydroxy deoxyguanosine in rat target DNA. Carcinogenesis 1987;8: 1959-61.
81. Cerutti PA. Oxidant stress and carcinogenesis. Europ J Clin Invest 1991;21:1-5.
82. Ames BN, Shigenage MK. Oxidants are a major contributor to cancer and aging. In: Halliwell B, Aruoma O, eds. DNA and Free Radicals. New York: Ellis Horwood Ltd., 1993:3-15.
83. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-208.
84. Pariza MW, Boutwell RK. Historical perspective: calories and energy expenditure in carcinogenesis. Am J Clin Nutr 1987;45:151-6.
85. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997;278:1407-11.
86. Maeda H, Gleiser CA, Masora EJ, et al. Nutritional influences on aging of Fischer 344 rats: II. Pathology. J Gerontol 1985;40:671-88.
87. Chung MH, Kasai H, Nishimura S, Yu BP. Protection of DNA damage by dietary restriction. Free Rad Biol Med 1992;12:523-5.
88. Cohen LA. Diet and cancer. Sci Amer 1987;257: 42-8.
89. Gey KF. Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. Br Med Bull 1993;49:679-99.
90. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992;3:194-202.
91. Packer L. Vitamin E is nature's master antioxidant. Sci Med 1994;1:54-62.
92. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6.
93. Yong L-C, Brown CC, Schatzkin A, et al. Intake of vitamins E, C, and A and risk of lung cancer. Am J Epidemiol 1997;146:231-43.
94. Garland M, Willett WC, Manson JE, Hunter DJ. Antioxidant micronutrients and breast cancer. J Am Coll Nutr 1993;12:400-11.
95. Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994;331:141-7.
96. Willett W, Morris JS, Pressel S, et al. Prediagnostic serum selenium and risk of cancer. Lancet 1983;2: 130-4.
97. Salonen JT, Alfthan G, Huttunen JK, Puska P. Association between serum selenium and the risk of cancer. Am J Epidemiol 1984;120:342-9.
98. Statland BE. Nutrition and cancer. Clin Chem 1992; 38:1587-94.
99. Block G. The data support a role for antioxidants in reducing cancer risk. Nutr Rev 1992;50:207-13.
100. Austoker J. Reducing alcohol intake. Br Med J 1994; 308:1549-52.
101. Thorogood M, Mann J, Appleby P, McPherson K. Risk of death from cancer and ischemic heart disease in meat and non-meat eaters. Br Med J 1994;308: 1667-70.
102. Tang ZC, Shivapurkar N, Frost A, Alabaster O. The effect of dietary fat on promotion of mammary and colon cancer in a dual-organ rat carcinogenesis model. Nutr Cancer 1996;25:151-9.
103. Gann PH, Hennekins CH, Sacks FM, et al. Prospective study of plasma fatty acid and risk of prostate cancer. J Natl Cancer Inst 1994;86:281-6.
104. Kennedy TP, Rao NV, Hopkins C, et al. Role of reactive oxygen species in reperfusion injury of the rabbit lung. J Clin Invest 1989;83:1326-35.
105. Cross CE (Moderator). Oxygen radicals and human disease. Ann Intern Med 1987;107:526-45.
106. Dart RC, Sanders AB. Oxygen free radicals and myocardial reperfusion injury. Ann Emerg Med 1988;17: 53-8.
107. Davies SW, Ranjadayalank K, Wickens DG, et al. Lipid peroxidation associated with successful thrombolysis. Lancet 1990;335:741-3.
108. Jaarsveld HV, Kuyl JM, Alberts DW. Antioxidant vitamin supplementation of smoke-exposed rats partially protects against myocardial ischaemia/reperfusion injury. Free Rad Res Comm 1992;17:263-9.
109. Gallin JI, Malech HL. Update on chronic granulomatous disease of childhood. JAMA 1990;263: 1533-7.
110. Quie PG, White JG, Holmes B, et al. In vitro bactericidal capacity of human polymorphonuclear leukocytes: Diminished activity in chronic granulomatous disease of childhood. J Clin Invest 1967;46:668-75.
111. Halliwell B, Gutteridge JMC. The importance of free radicals and catalytic metal ions in human disease. Molec Aspects Med 1985;8:89-193.
112. Biemond P, Swaak AJG, vanEijk HG, Koster JF. Superoxide dependent iron release from ferritin in inflammatory diseases. Free Rad Biol Med 1988;4: 185-98.
113. Wikby A, Johansson B, Fergunson F, Olsson J. Age-related changes in immune parameters in a very old population of Swedish people: A longitudinal study. Exp Gerontol 1994;5:531-41.
114. Nagel JE, Chrest FJ, Adler WH. Enumeration of T lymphocyte subsets by monoclonal antibodies in young and aged humans. J Immunol 1981;127: 2086-8.
115. Thoman ML, Weigle WO. Cell-mediated immunity in aged mice: An underlying lesion in IL2 synthesis. J Immunol 1982;128:2358-61.
116. Dardenne M, Boukaiba N, Gagnerault M-C, et al. Restoration of the thymus in aging mice by in vivo zinc supplementation. Clin Immunol Immunopathol 1993;66:127-35.
117. Duchateau J, Delepesse G, Vrijens R, Collet H. Beneficial effects of oral zinc supplementation on the immune response of old people. Am J Med 1981;70: 1001-4.
118. Fortes C, Forastiere F, Agabiti N, et al. The effect of zinc and vitamin A supplementation on immune response in an older population. J Am Geriatr Soc 1998;46:19-26.
119. Sun E, Xu H, Liu Q, et al. The mechanisms for the effect of selenium supplementation on immunity. Biol Trace Elem Res 1995;48:231-8.
120. Penn ND, Purkins I, Kelleher J, et al. The effect of dietary supplementation with vitamins A, C, and E on cell-mediated immune function in elderly long-stay patients: A randomized controlled study. Age Ageing 1991;20:169-74.
121. Meydani SN, Barklund MP, Liu S, et al. Vitamin E supplementation enhances cell-mediated immunity in healthy subjects. Am J Clin Nutr 1990;52:557-63.
122. Chandra RK. Effect of vitamins and trace-element supplementation on immune responses and infection in elderly patients. Lancet 1992;340:1124-7.
123. Bodden JD, Bendich A, Kemp FW, et al. Daily micronutrient supplements enhance delayed-hypersensitivity skin test responses in older people. Am J Clin Nutr 1994;60:337-47.
124. Quintanilha AT, Packer L. Vitamin E, physical exercise and tissue oxidative damage. Biology of Vitamin E. London: Pitman Books, 1983:56-69 (CIBA Foundation Symposium 101).
125. Dillard CJ, Litov RE, Savin WM, Dumelin EE, Tappel AL. Effects of exercise, vitamin E, and ozone on pulmonary function and lipid peroxidation. J Appl Physiol 1978;45:927-32.
126. Shi X, Flynn DC, Porter DW, et al. Efficacy of taurine based compounds as hydroxyl radical scavengers in silica induced peroxidation. Ann Clin Lab Sci 1997;27:365-74.
127. Pryor WA, Church DF. Aldehydes, hydrogen peroxide and organic radicals as mediators of ozone toxicity. Free Rad Biol Med 1991;11:41-6.
128. Sunderman FW Jr. Lipid peroxidation as a mechanism of acute nickel toxicity. Toxicol Environ Chem 1987;15:59-69.
129. Pascoe GA, Reed DJ. Vitamin E protection against chemical-induced cell injury. Arch Biochem Biophys 1987;256:159-66.
130. Burk RF, Lawrence RA, Lane JM. Liver necrosis and lipid peroxidation in the rat as the result of paraquat and diquat administration. J Clin Invest 1980;65:1024-31.
131. Knight JA, Pieper RK, Smith SE, Crockett HH. Increased urinary lipoperoxides in drug abusers. Ann Clin Lab Sci 1988;18:374-7.
132. Rice-Evans C, Halliwell B, Lunt GG, eds. Free Radicals and Oxidative Stress: Environment, Drugs and Food Additives. Portland Press, London, 1995.